The Role of Cyclin-dependent Kinase Inhibitor p27 in Squamous Cell Carcinoma of the Esophagus
Authors:
- Osamu MatsubaraOMOsamu Matsubara
- Hiroyuki WakiyamaHWHiroyuki Wakiyama
- Susumu TanakaSTSusumu Tanaka
- 1 January 2001
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 197 (3) , 157-164
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1Breast Cancer Research and Treatment, 1998
- Positive correlation between P27Kip1 expression and progression of human esophageal squamous cell carcinomaInternational Journal of Cancer, 1998
- Association of p27Kipl Levels With Recurrence and Survival in Patients With Stage C Prostate CarcinomaJNCI: Journal of the National Cancer Institute, 1998
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Novel INK4 Proteins, p19 and p18, Are Specific Inhibitors of the Cyclin D-Dependent Kinases CDK4 and CDK6Molecular and Cellular Biology, 1995
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994
- Braking the cycleCell, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.Proceedings of the National Academy of Sciences, 1993